84-1121-18 [取扱停止]Advanced Glycosylation Endproduct (AGE, CML, Ne-Carboxymethyllysine) 20ul A0909-75G

※お見積書はカートで印刷できます

冷凍 保管・搬送時に冷凍が必要な商品です。

特徴

  • Advanced glycation endproducts induce changes in glucose consumption, lactate production, and ATP levels in SH-SY5Y neuroblastoma cells by a redox-sensitive mechanism.
  • Advanced glycation endproducts (AGEs) accumulate on long-lived proteins, including beta-amyloid plaques in Alzheimer's disease.
  • They are suggested to contribute to neuronal dysfunction and cell death.
  • A recent study at Neuroimmunological Cell Biology Unit, Leipzig, Germany investigated the effects of a model AGE upon glucose metabolism and energy production in a neuroblastoma cell line.
  • AGEs decrease cellular ATP levels and increase glucose consumption and lactate production.
  • All of the AGE-induced metabolic changes can be attenuated by antioxidants such as (R+)-alpha-lipoic acid and 17beta-estradiol.
  • These antioxidants may become useful drugs against (AGE-mediated) effects in neurodegeneration through their positive effects on cellular energy metabolism.
  • Reaction of amino groups in protein with glucose leads to the formation of advanced glycation end products (AGE) through the early products such as Schiff base and Amadori rearrangement products.
  • Recent immunological studies using anti-AGE antibody demonstrated the presence of AGE-modified proteins in several human tissues:(i) human lens (non-diabetic and non-cataractous), (ii) renal proximal tubules in patients with diabetic nephropathy and chronic renal failure, (iii) diabetic retina, (iv) peripheral nerves of diabetic neuropathy, (v) atherosclerotic lesions of arterial walls, (vi) b2-microglobulin forming anyloid fibrils in patients with hemodialysis-related amyloidosis, (vii) senile plaques of patients with Alzheimer disease, (viii) peritoneum of CAPD patients, (ix) skin elastin in actinic elastosis, and (x) ceroid/lipofusion deposits.
  • These results suggest a potential role of AGE-modification in normal aging as well as age-enhanced disease processes.
  • Applications:Suitable for use in ELISA.
  • Other applications not tested.
  • Recommended Dilution:ELISA: 1:1000Optimal dilutions to be determined by the researcher.
  • Storage and Stability:Lyophilized and reconstituted products are stable for 12 months after receipt at -20°C.
  • Reconstitute with sterile ddH2O.
  • Aliquot to avoid repeated freezing and thawing.
  • Store at -20°C.
  • For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
  • Further dilutions can be made in assay buffer.

仕様

  • Size:20ul
  • Host:rabbit
  • Grade:Serum
  • Purity:Serum
  • Form:Supplied as a lyophilized powder in PBS, pH 7.2. Reconstitute in ddH2O.
  • Specificity:Recognizes Ne-Carboxymethyllysine (CML)
  • Isotype:IgG
  • Calc Applications Abbrev:E
  • Immunogen:Nε -(Carboxymethyl)lysine KLH-conjugated
  • Shelf Life:1year
  • EU Commodity Code:30021010
  • この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
  • 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
  • 【試薬に関するお問合せ】
  • アズワン株式会社 試薬・プロセス材料グループ
  • TEL:06-6447-8641
  • FAX:06-6447-8642
  • E-mail:[email protected]
アズワン品番
84-1121-18
型番
A0909-75G
入り数
1個
標準価格
85,000円(税抜)
WEB価格
-円
取扱停止
アズワン在庫 [?]
数量

※お気に入り機能はログイン後にご利用いただけます

よくあるご質問

よくあるご質問(FAQ)

掲載カタログ情報

掲載カタログ名 掲載ページ

次の商品を登録しました。

商品計:

お買い物を続ける カートを見る